This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
14 Nov 2025

Grünenthal PRO is joining SHL Medical’s alliance partnership network

The strategic collaboration will expand final assembly service for Molly® autoinjectors

Grünenthal PRO, the contract development and manufacturing organization (CDMO) division of Grünenthal offering a range of services including final assembly of autoinjectors, is entering into a non-exclusive partnership with SHL Medical, a world-leading solutions provider of advanced drug delivery systems. Through this collaboration, Grünenthal PRO will offer final assembly, packaging and labelling of Molly® autoinjector. 

Grünenthal PRO will expand its capacity for final assembly of SHL autoinjectors by installing additional assembly lines in its Origgio, Italy facility in 2026. These new pre-validated lines for Molly® 1.0 and 2.25 mL autoinjector platform will enhance speed-to-market for pharma and biotech companies, building on Grünenthal’s 10-year experience in SHL autoinjector assembly services. 

In parallel, SHL customers will benefit from access to Grünenthal PRO’s established expertise and capacity in delivering high quality, reliable contract manufacturing services.   

“Speed-to-market is a decisive advantage in today’s biopharma landscape,” says Victor Barbosa, Executive Vice President of Global Operations at Grünenthal. “With our deep expertise in autoinjector final assembly and the new high-speed line launching in 2026, Grünenthal is uniquely positioned to deliver agile, large-scale solutions. Our collaboration with SHL enhances this capability, reinforcing our role as a trusted CDMO partner for injectable therapies worldwide.” 

Molly® is a single-dose autoinjector built on modular platform technology that helps pharma and biotech companies reduce initial investments and accelerate timelines. Molly boasts an unparalleled track record in combination product approvals and is designed to meet the evolving requirements of future autoinjectors. 

Markus Puusepp, SHL Medical’s Chief Growth Officer, commented on the collaboration: "This new partnership builds on several years of successful project collaboration between SHL Medical and Grünenthal PRO for joint customers. We’re excited to deepen our collaboration by officially welcoming Grünenthal PRO as a strategic partner, further strengthening our trusted relationship.” 

The new Molly® autoinjector assembly line to be installed by Grünenthal PRO will be procured from SHL Advantec, a sub-group of SHL Medical and a global provider of high-performance, fully integrated precision tooling and advanced automation solutions for the healthcare sector and other industries.  
 

Mentioned Companies
SHL Medical
View company profile